Yang Shen, Shuhong Yu, Yuefeng Zhang, Siyu Wang, Jiayu Chen, Yangtao Xu, Xinyao Hu, Jiayi Li, Shan Jiang, Ling Wang, Le Xu, Zhuolin Zhou, Junjian Deng, Biao Chen, Ximing Xu
BACKGROUND: As one of the most common diseases in terms of cancer-related mortality worldwide, gastric adenocarcinoma (GA) frequently develops peritoneal metastases (PMs) in advanced stages. Systemic therapy or optimal supportive care are recommended for advanced GA; however, patients frequently develop drug resistance. Surgical resection is not recommended for stage IV patients, and there have been some controversies regarding the role of it in GA patients with PMs. The aim of the study was to preliminarily evaluate the possible effect of surgical treatments on patients with only PMs from GA...
April 30, 2024: Journal of Gastrointestinal Oncology